Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia

Oral Leukoplakia Clinical Trial

Official title:

Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00155337
• Other study ID #: 9361700753
• Status: Completed
• Phase: Phase 4
• First received: September 8, 2005
• Last updated: December 20, 2012
• Start date: August 2004
• Est. completion date: December 2007

Study information

• Verified date: December 2012
• Source: National Taiwan University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Interventional

Clinical Trial Summary

Photodynamic therapy for oral leukoplakia and erythroleukoplakia

Description:

Photodynamic therapy for oral leukoplakia and erythroleukoplakia

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: December 2007
• Est. primary completion date: December 2007
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 20 Years to 80 Years

Eligibility

Inclusion Criteria:

• patients with leukoplakia or erythroleukoplakia

Exclusion Criteria:

• oral cancers

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Leukoplakia
• Leukoplakia, Oral
• Oral Leukoplakia

Intervention

Procedure:
• photodynamic therapy

Locations

Country	Name	City	State
Taiwan	National Taiwan University Hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	End of 8 treatments
Secondary	Regression of lesions